Sensirion opens additional production building in Debrecen

10-Apr-2025
Computer-generated image

Symbol image

Sensirion, a leading global manufacturer of environmental and flow sensors, has successfully completed the expansion of its production facility in Debrecen, Hungary. The additional building comprises new production and logistics capacities on an area of around 7,000 m2. This will significantly increase the production capacity for sensor modules in order to support Sensirion's high growth ambitions. Sensirion is also strengthening its position as an attractive employer with secure jobs and good working conditions at the Debrecen site.

Module production site for high-quality applications

Sensirion opened the Debrecen site five years ago. Since then, millions of sensors and modules have been manufactured in Hungary and delivered from here to customers worldwide. Sensor modules are primarily produced for applications in the demanding markets of medical technology and the automotive industry. For the past year, leakage modules for the detection of A2L refrigerants have also been manufactured for the American market. The site in Debrecen has thus established itself as a strategically important module production site for Sensirion.

Sustainable building technology

The extension is attached to the existing building. Additional ISO 7 class cleanrooms were added to the production facility, allowing production steps to be carried out in an environment with the highest standards of cleanliness. Great importance was also attached to sustainability - similar to the production facility in Stäfa, Switzerland. The new building was integrated into the existing energy system and is based on a reversible geothermal heat pump. This is linked to a storage system together with a heat recovery system. A photovoltaic system completes the completely fossil-free overall system. With the installed solar power, Sensirion in Debrecen can generate around 25 % of its own electricity requirements. The expansion was built and financed by a local build-to-suit partner. Sensirion has signed a long-term lease agreement.

New jobs

The expansion of the production facility in Debrecen is an important strategic step for Sensirion and is in line with the company's sustainable growth strategy and the desire to create more jobs in Debrecen. The high-tech company relies on a steadily growing team of qualified and committed employees from various technical disciplines in Hungary. These include process engineering, materials science, chemistry, electrical engineering, automation and mechanical engineering.

The expansion will have no impact on jobs in Switzerland. Sensirion is also planning to expand its production capacity in Switzerland in the medium term.

"We are proud of the Debrecen site and see great potential for growth. This is mainly due to the dedicated and highly competent team," says Franziska Brem, VP Operations at Sensirion. "We stand for long-term and sustainable growth and want to further establish ourselves as an employer with secure jobs and good working conditions in Debrecen."

Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.

Other news from the department manufacturing

Most read news

More news from our other portals

Last viewed contents

Vetter Marks the Start of New Clinical Site Con­struction with Ground­breaking Ceremony - Vetter continues to expand in the US

Vetter Marks the Start of New Clinical Site Con­struction with Ground­breaking Ceremony - Vetter continues to expand in the US

A New Era Begins: BioSpring Builds High-Tech Manufacturing Facility for Pharmaceutical Nucleic Acid APIs

A New Era Begins: BioSpring Builds High-Tech Manufacturing Facility for Pharmaceutical Nucleic Acid APIs

GEA invests EUR 80 million in a pharmaceutical technology center for freeze-drying systems in Germany - First product chambers in the “Factory of the Future”

GEA invests EUR 80 million in a pharmaceutical technology center for freeze-drying systems in Germany - First product chambers in the “Factory of the Future”

PL BioScience Announces Major Site Expansion - New 1,200 m² facility in Aachen expands headquarters to support company growth and
scale Human Platelet Lysate production

PL BioScience Announces Major Site Expansion - New 1,200 m² facility in Aachen expands headquarters to support company growth and scale Human Platelet Lysate production

Stora Enso’s billion-euro investment in renewable packaging - Europe's most modern consumer board production line inaugurated in Finland

Stora Enso’s billion-euro investment in renewable packaging - Europe's most modern consumer board production line inaugurated in Finland

NextPharma announces the appointment of Ajeeth Enjeti as CEO to succeed Peter Burema

NextPharma announces the appointment of Ajeeth Enjeti as CEO to succeed Peter Burema

Dr. Roland Durner becomes new CEO of Bioengineering AG

Dr. Roland Durner becomes new CEO of Bioengineering AG

GDCh Award for Biocatalysis for Sebastian Gergel

GDCh Award for Biocatalysis for Sebastian Gergel

Michael Grosse to succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG - Grosse to take over as Group CEO on July 1, 2025

Michael Grosse to succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG - Grosse to take over as Group CEO on July 1, 2025

WACKER BIOSOLUTIONS under New Leadership - Susanne Leonhartsberger will leave the company at her own request at the end of 2024.

WACKER BIOSOLUTIONS under New Leadership - Susanne Leonhartsberger will leave the company at her own request at the end of 2024.

DMC Biotechnologies announces Dr. Jim Flatt as CEO - DMC seeking to transform how the world makes chemicals

DMC Biotechnologies announces Dr. Jim Flatt as CEO - DMC seeking to transform how the world makes chemicals

Merck: New CEOs for Life Science and Healthcare business sectors and New Chief People Officer - Appointment of three internal senior executives ensures strategic continuity with a new era of leadership

Merck: New CEOs for Life Science and Healthcare business sectors and New Chief People Officer - Appointment of three internal senior executives ensures strategic continuity with a new era of leadership